Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income per Common Share (Tables)

6 Months Ended

May 31, 2020

The following table sets forth the calculation of basic and diluted net income per common share:


	Three Months Ended				Six Months Ended
	May 31, 2020		May 31, 2019		May 31, 2020		May 31, 2019
Numerator:
Net Income	$	953,338	$	53,673	$	1,640,304	$	329,550

Denominator:
Weighted-average shares outstanding-basic		7,545,613		7,803,333		7,543,376		7,802,344

Dilutive common shares issuable upon exercise of stock options		566,676		617,903		577,078		619,798

Weighted-average shares-diluted		8,112,289		8,421,236		8,120,454		8,422,142

Net income per common share:
Basic	$	0.13	$	0.01	$	0.22	$	0.04

Diluted	$	0.12	$	0.01	$	0.20	$	0.04